Erste Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.4M | Buy |
2,326,489
+96,589
| +4% | +$3.21M | 0.65% | 31 |
|
|
2025
Q1 | $65.4M | Buy |
2,229,900
+220,000
| +11% | +$6.46M | 0.84% | 30 |
|
|
2024
Q4 | $66.4M | Sell |
2,009,900
-175,000
| -8% | -$5.78M | 0.81% | 28 |
|
|
2024
Q3 | $97.2M | Sell |
2,184,900
-70,000
| -3% | -$3.11M | 1.16% | 12 |
|
|
2024
Q2 | $97.3M | Sell |
2,254,900
-25,000
| -1% | -$1.08M | 1.29% | 11 |
|
|
2024
Q1 | $66.7M | Buy |
2,279,900
+172,000
| +8% | +$5.03M | 0.91% | 23 |
|
|
2023
Q4 | $47M | Buy |
2,107,900
+413,700
| +24% | +$9.22M | 0.69% | 41 |
|
|
2023
Q3 | $41.9M | Hold |
1,694,200
| – | – | 0.72% | 37 |
|
|
2023
Q2 | $47.9M | Hold |
1,694,200
| – | – | 0.85% | 26 |
|
|
2023
Q1 | $38.9M | Hold |
1,694,200
| – | – | 0.74% | 38 |
|
|
2022
Q4 | $47.5M | Hold |
1,694,200
| – | – | 1% | 18 |
|
|
2022
Q3 | $47.9M | Sell |
1,694,200
-35,000
| -2% | -$990K | 1.07% | 14 |
|
|
2022
Q2 | $38.3M | Buy |
1,729,200
+100,000
| +6% | +$2.22M | 0.85% | 29 |
|
|
2022
Q1 | $47.4M | Buy |
1,629,200
+51,000
| +3% | +$1.49M | 0.91% | 24 |
|
|
2021
Q4 | $53M | Buy |
1,578,200
+435,000
| +38% | +$14.6M | 0.95% | 19 |
|
|
2021
Q3 | $52.8M | Buy |
1,143,200
+59,300
| +5% | +$2.74M | 1.04% | 13 |
|
|
2021
Q2 | $59.6M | Buy |
1,083,900
+30,000
| +3% | +$1.65M | 1.19% | 12 |
|
|
2021
Q1 | $54.3M | Hold |
1,053,900
| – | – | 1.33% | 9 |
|
|
2020
Q4 | $46.9M | Buy |
1,053,900
+66,400
| +7% | +$2.96M | 1.3% | 10 |
|
|
2020
Q3 | $34.5M | Buy |
987,500
+77,400
| +9% | +$2.7M | 1.18% | 13 |
|
|
2020
Q2 | $48.6M | Sell |
910,100
-125,300
| -12% | -$6.69M | 1.94% | 4 |
|
|
2020
Q1 | $36.7M | Sell |
1,035,400
-43,300
| -4% | -$1.54M | 2.14% | 3 |
|
|
2019
Q4 | $51.8M | Buy |
1,078,700
+268,000
| +33% | +$12.9M | 2.29% | 5 |
|
|
2019
Q3 | $26.4M | Buy |
810,700
+116,000
| +17% | +$3.78M | 1.41% | 17 |
|
|
2019
Q2 | $34.6M | Buy |
694,700
+120,000
| +21% | +$5.98M | 1.84% | 7 |
|
|
2019
Q1 | $38.6M | Buy |
574,700
+15,100
| +3% | +$1.01M | 2.16% | 5 |
|
|
2018
Q4 | $25.3M | Buy |
+559,600
| New | +$25.3M | 1.7% | 10 |
|